WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
This report presents the findings of a short-term study to examine the risk of TB among health care workers. It discusses the possible effects of federal guidelines, responses to resurgent TB, and proposed strategies for eliminating TB in the United States and worldwide.
This report discusses ways to reduce the spread and impact of infectious diseases, such as the six most deadly: HIV/AIDS, pneumonia, diarrhea, malaria, measles, and TB.
This report provides findings from a study designed to compare a whole-blood interferon gamma assay, the QuantiFERON-TB test, with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection and to identify factors associated with discordance between the tests.
This report summarizes the 2017 client-level partner services data submitted by CDC-funded jurisdictions in the United States and dependent areas (i.e., Puerto Rico and U.S. Virgin Islands).
Treatment Action Group did an analysis of ongoing research in the pipeline for Gonorrhea, Chlamydia, and Syphilis. This study identified that the current toolbox for addressing gonorrhea, chlamydia, and syphilis is inadequate.
This white paper outlines NCHHSTP’s strategic vision for program collaboration and service integration, building on and refining concepts.
This report summarizes the test-level National HIV Prevention Program Monitoring and Evaluation (NHM&E) data for CDC funded tests conducted in 2017 in the United States (U.S.) and dependent areas (Puerto Rico and U.S. Virgin Islands).
